Report HighlightsThis report provides:An overview of the global market for growth of immunoassay technology in clinical, food safety, and environmental areas; this report focuses on diabetes lboratory immunoassa...
|
$ 4400
|
|
|
The North American injectable drug delivery technologies market was valued at $9.3 billion in 2012; it is expected to reach $16.6 billion by 2017 at a CAGR of 12.3% from 2012 to 2017. Injectable drug delivery technologies are the combination of tw...
|
$ 4650
|
|
|
The global injectable drug delivery technologies market was valued at $22.5 billion in 2012, and is expected to reach $43.3 billion by 2017 at a CAGR of 14.0% from 2012 to 2017. Injectable drug delivery technologies are the combination of two majo...
|
$ 4650
|
|
|
Type 2 Diabetes – Pipeline Review, H1 2013
Summary
Global Markets Direct’s, ''Type 2 Diabetes - Pipeline Review, H1 2013'', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic develop
|
$ 2500
|
|
|
Type 1 Diabetes (Juvenile Diabetes) – Pipeline Review, H1 2013
Summary
Global Markets Direct’s, ''Type 1 Diabetes (Juvenile Diabetes) - Pipeline Review, H1 2013'', provides an overview of the indication’s therapeutic pipeline. This report provide
|
$ 2000
|
|
|
Diabetes – Pipeline Review, H1 2013
Summary
Global Markets Direct’s, ''Diabetes - Pipeline Review, H1 2013'', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for Diabe
|
$ 2000
|
|
|
GlobalData's clinical trial report, Gestational Diabetes Global Clinical Trials Review, H1, 2013 provides data on the Gestational Diabetes clinical trial scenario. This report provides elemental information and data relating to the...
|
$ 2500
|
|
|
The European market for diabetes diagnosis, treatment and drug delivery is expected to exceed €7.7 billion by 2019.This market includes traditional blood glucose meters, continuous glucose monitoring systems, blood glucose test strips,...
|
$ 10995
|
|
|
GBI Research, the leading business intelligence provider, has released its latest research Diabetes Therapeutics Market in India to 2018 - Rapid Uptake of DPP-IV Inhibitors, GLP-1 Agonists and Expanding Insulin Segment to Drive Growth&rdquo...
|
$ 3500
|
|
|
REPORT HIGHLIGHTSThis report provides:An overview of the global market for diabetes therapies and diagnosticsAnalyses of global market trends, with data from 2011, estimates for 2012, and projections of...
|
$ 5450
|
|
|
REPORT HIGHLIGHTSThis report provides:An overview of the global market for prescription generic drugs used in the treatment of diabetes and devices and instruments used for diagnosis and monitoring of diabetes, ...
|
$ 4400
|
|
|
Diabetes refers to a series of metabolic disorder syndrome such as sugars, proteins, fat, water and electrolyte that are triggered by islet dysfunction and insulin resistance, and the latter is caused by the actions of various pathogenic factors s...
|
$ 2800
|
|
|
Pre-Diabetes/Impaired Glucose Tolerance – Pipeline Review, H2 2012
Summary
Global Markets Direct’s, ''Pre-Diabetes/Impaired Glucose Tolerance - Pipeline Review, H2 2012'', provides an overview of the indication’s therapeutic pipeline. This report
|
$ 2000
|
|
|
There has been a dramatic increase in the incidence of diabetes worldwide, which has been exacerbated by the growing obesity problem across the globe. Once thought of as primarily a childhood disease--sometimes referred to as juvenile diabetes, no...
|
$ 3400
|
|
|
TechNavio''s analysts forecast the Global Diabetes Drugs market to grow at a CAGR of 9.7 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increase in diabetic population. The Global Diabetes Drugs mar
|
$ 1500
|
|
|
North America Diabetes Care Devices Market Outlook to 2018 - Glucose Monitoring and Insulin Delivery
Summary
GlobalData’s new report, “North America Diabetes Care Devices Market Outlook to 2018 - Glucose Monitoring and Insulin Delivery” provide
|
$ 3500
|
|
|
Europe Diabetes Care Devices Market Outlook to 2018 - Glucose Monitoring and Insulin Delivery
Summary
GlobalData’s new report, “Europe Diabetes Care Devices Market Outlook to 2018 - Glucose Monitoring and Insulin Delivery” provides key market d
|
$ 3500
|
|
|
Asia-Pacific Diabetes Care Devices Market Outlook to 2018 - Glucose Monitoring and Insulin Delivery
Summary
GlobalData’s new report, “Asia-Pacific Diabetes Care Devices Market Outlook to 2018 - Glucose Monitoring and Insulin Delivery” provides
|
$ 3500
|
|
|
Middle East and Africa Diabetes Care Devices Market Outlook to 2018 - Glucose Monitoring and Insulin Delivery
Summary
GlobalData’s new report, “Middle East and Africa Diabetes Care Devices Market Outlook to 2018 - Glucose Monitoring and Insulin
|
$ 3500
|
|
|
South and Central America Diabetes Care Devices Market Outlook to 2018 - Glucose Monitoring and Insulin Delivery
Summary
GlobalData’s new report, “South and Central America Diabetes Care Devices Market Outlook to 2018 - Glucose Monitoring and I
|
$ 3500
|
|
|